USFDA completes inspection of Lupin’s Aurangabad facility

17 Feb 2020 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Aurangabad, India facility. The inspection was carried out between February 10, 2020 and February 14, 2020. The inspection concluded without any observation.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Lupin Share Price

2168.05 -10.15 (-0.47%)
20-Jan-2026 09:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.80
Dr. Reddys Lab 1166.00
Cipla 1387.50
Zydus Lifesciences 880.35
Lupin 2168.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×